Pharmaceutical Technology on MSN5d
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
"FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease" was originally created and published by Pharmaceutical ...
WSAV Savannah on MSN2mon
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (WPIX) – The U.S ... The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson ...
pharmaphorum2y
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
Healio21d
FDA approves epinephrine nasal spray for children aged as young as 4 years
Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...
Yahoo Finance5d
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
Johnson & Johnson (J&J ... In January, 2025, J&J’s nasal spray Spravato secured a label expansion from the FDA for use as a single agent in adults with major depressive disorder (who were ...